Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Tsai, Steven
BMT CTN CureAA, NCT06517641: Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemia	Not yet recruiting	2	60	US	Haploidentical donor bone marrow transplant, Unrelated donor bone marrow transplant	Medical College of Wisconsin, National Heart, Lung, and Blood Institute (NHLBI), National Cancer Institute (NCI), Sanofi	Severe Aplastic Anemia	08/28	02/29
SER-155-001, NCT04995653: A Multiple Dose Study to Evaluate Safety, Tolerability, PK, and Efficacy of SER-155 in Adults Undergoing HSCT	Completed	1	60	US	Vancomycin Pre-Treatment, Vancomycin Placebo, SER-155, SER-155 Placebo	Seres Therapeutics, Inc., Memorial Sloan Kettering Cancer Center	Allogeneic Hematopoietic Stem Cell Transplantation	07/24	07/24
Site, Investigator
SER-155-001, NCT04995653: A Multiple Dose Study to Evaluate Safety, Tolerability, PK, and Efficacy of SER-155 in Adults Undergoing HSCT	Completed	1	60	US	Vancomycin Pre-Treatment, Vancomycin Placebo, SER-155, SER-155 Placebo	Seres Therapeutics, Inc., Memorial Sloan Kettering Cancer Center	Allogeneic Hematopoietic Stem Cell Transplantation	07/24	07/24